The PharmaThene agreement may be a bigger deal than it appears on the surface.
PharmaThene is in the process of going public through an acquisition by Healthcare Acquisition Corporation (Amex: HAQ) ... scheduled to close this summer. The following is a power point presentation by HAQ for prospective investors, but it makes interesting reading as to what is forecast in revenues for Protexia.